Acceleron Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch XLRN and buy or sell other stocks, ETFs, and their options commission-free!

About XLRN

Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. 

CEO
Habib J. Dable, MBA
CEOHabib J. Dable, MBA
Employees
Employees
Headquarters
Rahway, New Jersey
HeadquartersRahway, New Jersey
Founded
2003
Founded2003
Employees
Employees

XLRN Key Statistics

Market cap
10.93B
Market cap10.93B
Price-Earnings ratio
-42.53
Price-Earnings ratio-42.53
Dividend yield
Dividend yield
Average volume
1.94M
Average volume1.94M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$189.99
52 Week high$189.99
52 Week low
$111.29
52 Week low$111.29

Stock Snapshot

Acceleron Pharma(XLRN) stock is priced at $178.75, giving the company a market capitalization of 10.93B. It carries a P/E multiple of -42.53.

On 2026-02-23, Acceleron Pharma(XLRN) shares started trading at —, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 1.94M.

Over the past 52 weeks, Acceleron Pharma(XLRN) stock has traded between a high of $189.99 and a low of $111.29.

Over the past 52 weeks, Acceleron Pharma(XLRN) stock has traded between a high of $189.99 and a low of $111.29.

People also own

Based on the portfolios of people who own XLRN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.